‘It really seems cruel’: drug giant’s brutal blow to Australian breast cancer patients
21 October 2020 - Terminally ill breast cancer patients will have to pay $1,600 a month for a lifesaving treatment, after the drug maker rejected a government subsidy.
Read on if you are interested in more tosh from Sue Dunleavy.